T (GLP 2) Research Peptide — Buy Dual GLP-1/GIP Co-Agonist (≥97% Purity)
T (GLP 2) (CAS 2023788-19-2) is a synthetic twincretin peptide that functions as a dual agonist at both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. As the first dual incretin co-agonist to demonstrate superior metabolic effects over GLP-1 monoagonism in clinical models, T (GLP 2) has become an essential research compound for studying incretin biology, metabolic disease, and adipose tissue regulation.
Mechanism of Action
T (GLP 2) simultaneously activates GLP-1R and GIPR, two class B GPCRs with complementary roles in incretin-mediated insulin secretion. GIP receptor activation augments insulin response and promotes lipid metabolism and adipogenesis regulation — effects not observed with GLP-1R agonism alone. The dual mechanism produces additive or synergistic effects on glycemic control, fat mass reduction, and energy expenditure in preclinical models, making T (GLP 2) an invaluable tool for comparative receptor pathway research.
Research Applications
- Dual incretin receptor co-agonism and signaling studies
- Glucose homeostasis and insulin secretion models
- Lipid metabolism, adipogenesis, and adipose biology research
- Energy expenditure and body composition studies
- Comparative GLP-1 vs. GIP receptor pathway analysis
Specifications
- Chemical Name: T (GLP 2)
- CAS Number: 2023788-19-2
- Molecular Weight: ~4,813 Da
- Purity: ≥97% (HPLC verified)
- Form: Lyophilized powder
- Available Sizes: 2mg, 5mg, 10mg
Storage & Handling
Store lyophilized T (GLP 2) at −20°C. Reconstitute with bacteriostatic water; store reconstituted solution at 4°C for up to 28 days. Avoid repeated freeze-thaw cycles. Handle under aseptic laboratory conditions.
For in-vitro laboratory research use only. Not for human or animal consumption. Not a drug, supplement, or medicinal product.
